GlassScriptPhysician profile
Raymond Delgado
NPI 1972152924
$6,590.60
in general payments reported to CMS, 2019-2025
26 companies · $449 in 2025
The $449 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,044 · 2022: $3,081 · 2023: $16.69 · 2025: $449.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $465.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $465.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $1,944.35 | 2021-2025 | Apretude |
| Gilead Sciences, INC. | $1,726.05 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $373.98 | 2021-2022 | |
| Abbvie INC. | $268.33 | 2021 | |
| Amgen INC. | $250.00 | 2021 | |
| Janssen Products, LP | $247.78 | 2021 | |
| Glaxosmithkline, LLC. | $225.22 | 2021-2023 | Trelegy Ellipta |
| Kowa Pharmaceuticals America, INC. | $171.40 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $168.82 | 2021-2022 | |
| Harmony Biosciences LLC | $160.99 | 2022 | |
| Eisai INC. | $159.96 | 2021-2022 | |
| Emd Serono, INC. | $144.43 | 2022 | |
| Lilly USA, LLC | $140.71 | 2021-2022 | |
| Theratechnologies INC. | $134.04 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $82.29 | 2021-2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $58.78 | 2021-2022 | |
| Novo Nordisk INC | $48.76 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $46.40 | 2021-2022 | |
| Jazz Pharmaceuticals INC. | $41.70 | 2021-2022 | |
| Antares Pharma, INC. | $38.78 | 2021-2022 | |
| Phadia US INC. | $36.73 | 2021-2022 | |
| Paratek Pharmaceuticals, INC. | $32.69 | 2021 | |
| Adlon Therapeutics L.P. | $30.56 | 2021 | |
| Medtronic, INC. | $24.10 | 2025 | Interstim |
| Acerus Pharmaceuticals Corporation | $17.39 | 2022 | |
| Napo Pharmaceuticals INC | $16.36 | 2025 | Mytesi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raymond Delgado listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.